Annual Review of Pharmacology and Toxicology

Papers
(The TQCC of Annual Review of Pharmacology and Toxicology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Lysosomal Ion Channels: What Are They Good For and Are They Druggable Targets?102
Synthetic Cannabinoids: A Pharmacological and Toxicological Overview98
CaMKII as a Therapeutic Target in Cardiovascular Disease79
Pollution of Soil by Pharmaceuticals: Implications for Metazoan and Environmental Health68
Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon56
How Biologics Have Changed the Drug Discovery Landscape50
Pharmacological Induction of Granulocyte Cell Death as Therapeutic Strategy49
Age-Related Perioperative Neurocognitive Disorders: Experimental Models and Druggable Targets49
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease48
Prenatal and Postnatal Pharmacotherapy in Down Syndrome: The Search to Prevent or Ameliorate Neurodevelopmental and Neurodegenerative Disorders46
Targeting G Protein–Coupled Receptors in Immuno-Oncological Therapies45
Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease42
Pharmacology of TRPC Channels and Its Potential in Cardiovascular and Metabolic Medicine42
Thioredoxin Reductase Inhibition for Cancer Therapy40
Understanding the Chemical Exposome During Fetal Development and Early Childhood: A Review40
Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications38
Endocrine-Disrupting Chemicals and Child Health37
Alcohol Use Disorder Treatment: Problems and Solutions36
The Nocebo Effect36
Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation34
Measuring Pharmacogene Variant Function at Scale Using Multiplexed Assays34
Roadmap for Achieving Universal Antiretroviral Treatment33
Chemogenetic Approaches to Probe Redox Pathways: Implications for Cardiovascular Pharmacology and Toxicology30
Biased Agonism: Lessons from Studies of Opioid Receptor Agonists30
Treating Sickle Cell Disease: Gene Therapy Approaches29
Apathy and Motivation: Biological Basis and Drug Treatment28
Harnessing the Power of Electronic Health Records and Genomics for Drug Discovery24
Phosphodiesterases: Evolving Concepts and Implications for Human Therapeutics24
Evolving Approaches for Pharmacological Therapy of Obesity24
Neuropathic Pain: Mechanisms, Sex Differences, and Potential Therapies for a Global Problem23
Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities23
0.025637149810791